EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 CareCloud Reports Second Quarter 2026 Results Revenue Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income SOMERSET, N.J., August 6, 2026 (GLOBE NEWSWIRE) - CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended June 30, 2026 and reaffirmed its full-year guidance. Second Quarter 2026 Financial Highlights: Revenue of $31.9 million, compared to $27.4 million in Q2 2025 GAAP net income of $1.1 million, compared to $2.9 million in Q2 2025 GAAP EPS of $0.00 per share, compared to $0.04 per share in Q2 2025 Adjusted EBITDA of $5.9 million, compared to $6.5 million in Q2 2025 Year-to-date 2026 Highlights: Revenue of $63.2 million, compared to $55.0 million in the same period last year GAAP net income of $2.0 million, compared to $4.9 million in the same period last year GAAP EPS of ($0.01) per share, compared to $0.02 per share in the same period last year Adjusted EBITDA of $11.3 million, compared to $12.1 million in the same…
Open exhibit ↗Current Report · Items 2.02, 7.01, 9.01 · 8-K
CareCloud, Inc.
CCLDNASDAQEQUITYCurrent
Results of Operations and Financial Condition · Regulation FD Disclosure
Item 2.02 Results of Operations and Financial Condition. On August 6, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.…
Company context
Current securities
Historical securities (1)
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item
2.02 Results of Operations and Financial Condition.
On
August 6, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein
by reference.
The
information furnished pursuant to Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure.
On
August 6, 2026, the Registrant provided slides to accompany its earnings presentation, a copy of which is attached hereto as Exhibit
99.2 and is incorporated herein by reference.
The
information furnished pursuant to Item 7.01 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
Filed exhibits (2)
EX-99.2
Open exhibit ↗